New Drugs and Regimens for Tuberculosis Disease Treatment in Children and Adolescents
Author(s) -
Anthony J. GarciaPrats,
Jeffrey R. Starke,
Brenda Waning,
Brian Kaiser,
James A. Seddon
Publication year - 2022
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piac047
Subject(s) - medicine , bedaquiline , clofazimine , rifapentine , tuberculosis , rifampicin , regimen , drug , adverse effect , intensive care medicine , disease , isoniazid , rifamycin , pediatrics , pharmacology , antibiotics , mycobacterium tuberculosis , leprosy , immunology , latent tuberculosis , pathology , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom